Edition:
India

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

111.78USD
23 Jan 2019
Change (% chg)

-- (--)
Prev Close
$111.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
260,711
52-wk High
$277.48
52-wk Low
$98.56

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.93 December 24 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 4 4 3
(3) HOLD 1 1 1 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.86 1.86 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2 37.35 42.06 32.62 --
Quarter Ending Jun-19 2 53.14 54.65 51.63 --
Year Ending Dec-19 6 213.12 214.80 212.20 198.23
Earnings (per share)
Quarter Ending Mar-19 3 0.93 1.02 0.76 0.66
Quarter Ending Jun-19 3 1.39 1.44 1.33 1.08
Year Ending Dec-19 6 5.51 5.70 5.25 5.62
LT Growth Rate (%) 2 25.00 30.00 20.00 27.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 41.70 45.66 3.97 9.51
Quarter Ending Jun-18 82.20 90.04 7.85 9.55
Quarter Ending Mar-18 43.02 56.16 13.14 30.54
Quarter Ending Dec-17 47.82 50.46 2.65 5.54
Quarter Ending Sep-17 30.91 33.38 2.46 7.96
Earnings (per share)
Quarter Ending Sep-18 1.03 1.32 0.29 28.65
Quarter Ending Jun-18 2.34 2.59 0.25 10.68
Quarter Ending Mar-18 1.29 1.55 0.26 20.34
Quarter Ending Dec-17 1.19 1.31 0.12 9.78
Quarter Ending Sep-17 0.61 0.69 0.08 12.38

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 37.35 37.35 36.71 35.71 --
Quarter Ending Jun-19 53.14 53.14 51.79 49.04 --
Year Ending Dec-19 213.12 213.12 207.16 204.23 198.23
Earnings (per share)
Quarter Ending Mar-19 0.93 0.93 0.85 0.83 0.66
Quarter Ending Jun-19 1.39 1.39 1.27 1.22 1.08
Year Ending Dec-19 5.51 5.51 5.31 5.23 5.62

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 1 0
Quarter Ending Jun-19 0 0 1 0
Year Ending Dec-19 0 0 3 0
Earnings
Quarter Ending Mar-19 0 0 2 0
Quarter Ending Jun-19 0 0 2 0
Year Ending Dec-19 0 0 2 0